Hosokawa Micron (6277) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
7 Aug, 2026Executive summary
Net sales for the third quarter ended June 30, 2026, rose 4.5% year-over-year to ¥60,911 million, driven by a weaker yen and resilient demand in certain sectors.
Operating profit declined 53.4% year-over-year to ¥2,650 million, impacted by higher labor costs, increased SG&A, and business restructuring expenses in Europe.
Profit attributable to owners of parent fell 50.1% year-over-year to ¥2,142 million.
Orders received increased 3.8% year-over-year, but backlog of orders slightly decreased by 0.9%.
Financial highlights
Gross profit decreased to ¥19,833 million from ¥20,590 million year-over-year.
Comprehensive income for the period was ¥6,393 million, down 3.6% year-over-year.
Earnings per share dropped to ¥146.20 from ¥290.06 in the prior year.
Cash and cash equivalents at period end were ¥30,332 million, down ¥752 million from the previous year-end.
Outlook and guidance
Full-year net sales forecast revised to ¥83,000 million, up 6.4% year-over-year.
Operating profit forecast at ¥4,500 million (down 36.2% year-over-year), ordinary profit at ¥5,200 million (down 32.6%), and profit attributable to owners of parent at ¥3,200 million (down 29.3%).
Earnings per share for the full year projected at ¥218.32.
Dividend forecast includes a ¥65.00 ordinary and ¥10.00 commemorative dividend, totaling ¥75.00 for year-end.
Latest events from Hosokawa Micron
- Sales up, profits down sharply; outlook steady, dividend raised, risks from costs and geopolitics.6277
Q2 2026 - Sales up, profits down on higher costs and one-time loss; FY2026 outlook steady.6277
Q1 2026 - Sales and profits fell on European weakness, but profit recovery and cost controls support FY2026 outlook.6277
Q4 2025 - Record sales and operating profit, but net profit fell; next year’s outlook is cautious.6277
Q4 2024 - Strong sales growth and higher profits, but full-year outlook signals profit decline.6277
Q3 2024 - Sales and profits declined, but comprehensive income soared on currency gains; major merger completed.6277
Q1 2025 - Net sales and operating profit fell, but interim profit hit a record high amid stable bookings.6277
Q2 2025 - Profit rose on lower extraordinary losses despite sales decline; treasury share buyback approved.6277
Q3 2025